Perspective Stories

ATHX
  over two months ago at Macroaxis 
By Raphi Shpitalnik
Today we may see the proof that Brickell Biotech would recover slower from the current drop as its shares fell 8.33% to Athersys's 8%. As many rational traders are trying to avoid healthcare space, it makes sense to break down Athersys a little further and understand how it stands against Brickell Biotech and other similar entities. We are going to inspect some of the competitive aspects of both Athersys and Brickell.
CVGW
  over two months ago at Macroaxis 
By Vlad Skutelnik
As many rational traders are trying to avoid consumer defensive space, it makes sense to focus on Calavo Growers a little further and understand how it stands against AdvancePierre Foods and other similar entities. We are going to recap some of the competitive aspects of both Calavo and AdvancePierre.
ASUR
  over two months ago at Macroaxis 
By Gabriel Shpitalnik
Today we may see the proof that Absolute Software would recover slower from the newest drop as its shares fell 4.57% to Asure Software's 0.86%. As many rational traders are trying to avoid technology space, it makes sense to sum up Asure Software a little further and understand how it stands against Absolute Software and other similar entities. We are going to discuss some of the competitive aspects of both Asure and Absolute.
CECE
  over two months ago at Macroaxis 
By Vlad Skutelnik
As many rational traders are trying to avoid industrials space, it makes sense to digest C E C a little further and understand how it stands against Advanced Emissions and other similar entities. We are going to discuss some of the competitive aspects of both C E and Advanced.
PLXP
  over two months ago at Macroaxis 
By Gabriel Shpitalnik
Merck Kgaa would recover faster from the current slide as its shares price went up 0.71% to Plx Pharma's 7.53%While some millenniums may be indifferent towards healthcare space, we will examine how healthy are Plx Pharma fundamentals compared to Merck Kgaa. We are going to focus on some of the competitive aspects of both Plx Pharma and Merck.
FCEL
  over two months ago at Macroaxis 
By Raphi Shpitalnik
It looks like Belden will continue to recover much faster as its share price surged up 0.45% today to Fuelcell Energy's 9.8101%. While some of us are excited about industrials space, we will evaluate how steady are Fuelcell Energy and Belden fundamentals. We are going to summarize some of the competitive aspects of both Fuelcell and Belden.
DSEY
  over two months ago at Macroaxis 
By Vlad Skutelnik
Today we may see the proof that Bright Horizons would recover much slower from the new pull down as its shares went up 1.12% to Diversey Holdings's 15.3333%. As many rational traders are trying to avoid consumer cyclical space, it makes sense to break down Diversey Holdings a little further and understand how it stands against Bright Horizons and other similar entities. We are going to inspect some of the competitive aspects of both Diversey and Bright.
ASRT
  over two months ago at Macroaxis 
By Raphi Shpitalnik
As many rational traders are trying to avoid healthcare space, it makes sense to review Assertio Holdings a little further and understand how it stands against FSD Pharma and other similar entities. We are going to break down some of the competitive aspects of both Assertio and FSD Pharma.
BNED
  over two months ago at Macroaxis 
By Raphi Shpitalnik
While some of us are excited about consumer cyclical space, we will evaluate how sound are Barnes Noble and National Vision fundamentals. We are going to discuss some of the competitive aspects of both Barnes and National.
ENTX
  over two months ago at Macroaxis 
By Raphi Shpitalnik
As many of us are excited about healthcare space, we will review both, Entera Bio and Brickell Biotech as a potential short-term opportunity. We are going to inspect some of the competitive aspects of both Entera and Brickell.